Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Identification of ADAM12 as a Novel Basigin Sheddase

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Methods and guidelines for measurement of glucagon in plasma

    Research output: Contribution to journalReviewResearchpeer-review

  2. Xeno-Free Propagation of Spermatogonial Stem Cells from Infant Boys

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion - A Review

    Research output: Contribution to journalReviewResearchpeer-review

  4. Glucagon Receptor Signaling and Glucagon Resistance

    Research output: Contribution to journalReviewResearchpeer-review

  5. Evolution and Medical Significance of LU Domain-Containing Proteins

    Research output: Contribution to journalReviewResearchpeer-review

  1. Investigating Intestinal Glucagon after Roux-en-Y Gastric Bypass Surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Methods and guidelines for measurement of glucagon in plasma

    Research output: Contribution to journalReviewResearchpeer-review

  3. The Liver-α-Cell Axis and Type 2 Diabetes

    Research output: Contribution to journalReviewResearchpeer-review

  4. Glucagon Receptor Signaling and Glucagon Resistance

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

The transmembrane glycoprotein basigin, a member of the immunoglobulin superfamily, stimulates matrix metalloproteinase (MMP)-mediated extracellular matrix (ECM) degradation and thereby drives cancer cell invasion. Basigin is proteolytically shed from the cell surface and high concentrations of soluble basigin in the blood dictates poor prognosis in cancer patients. A positive correlation between basigin and a disintegrin and metalloproteinase (ADAM)-12 in serum from prostate cancer patients has been reported. Yet, the functional relevance of this correlation is unknown. Here, we show that ADAM12 interacts with basigin and cleaves it in the juxtamembrane region. Specifically, overexpression of ADAM12 increases ectodomain shedding of an alkaline phosphatase-tagged basigin reporter protein from the cell surface. Moreover, CRISPR/Cas9-mediated knockout of ADAM12 in human HeLa carcinoma cells results in reduced shedding of the basigin reporter, which can be rescued by ADAM12 re-expression. We detected endogenous basigin fragments, corresponding to the expected size of the ADAM12-generated ectodomain, in conditioned media from ADAM12 expressing cancer cell-lines, as well as serum samples from a healthy pregnant donor and five bladder cancer patients, known to contain high ADAM12 levels. Supporting the cancer relevance of our findings, we identified several cancer-associated mutations in the basigin membrane proximal region. Subsequent in vitro expression showed that some of these mutants are more prone to ADAM12-mediated shedding and that the shed ectodomain can enhance gelatin degradation by cancer cells. In conclusion, we identified ADAM12 as a novel basigin sheddase with a potential implication in cancer.

Original languageEnglish
Article number1957
JournalInternational Journal of Molecular Sciences
Volume20
Issue number8
ISSN1661-6596
DOIs
Publication statusPublished - 22 Apr 2019

    Research areas

  • ADAM12 Protein/chemistry, Amino Acid Sequence, Basigin/chemistry, CRISPR-Cas Systems, Cell Line, Gene Expression, Gene Knockdown Techniques, Genes, Reporter, Humans, Mutation, Substrate Specificity

ID: 58217877